Company intelligence / Profile preview

Yeonje

Seo-gu, Incheon, South Korealeauclaire.kr ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Yeonje has developed a broad portfolio of cosmetic formulations using advanced extraction/purification methods for natural ingredients such as Cordyceps species. The company leverages proprietary skin diagnosis systems and novel drug delivery platforms but does not report clinical trial results for pharmaceutical candidates. Its main commercial activity is in skincare/cosmetics with ongoing R&D in biomedicine.

Therapeutic areas: OtherDermatologyImmunology
Modalities: Small molecule (natural product extracts)Biologic (stem cell culture fluid)Nanoparticle (nano/liposome formulations)Hydrogel-based drug delivery therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Yeonje.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yeonje.

Explore the full profile